Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-22

FDA Approved: TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25% — Original Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved NorthStar RxLLC's timolol maleate ophthalmic gel forming solution 0.25% under an Original Application (ANDA) for open-angle glaucoma and ocular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol Maleate Ophthalmic Gel Forming Solution 0.25% (timolol maleate ophthalmic gel forming solution 0.25%)

Snippet

ORIG AP for TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25%)